With Cardiovascular Disease Becoming The Most Common Cause Of Death In People With Diabetes, Interest In The Assessment And Treatment Of Heart Disease In These Patients Has Been Reawakened.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c74914) has announced the addition of "Diabetic Cardiology" to their offering With cardiovascular disease becoming the most common cause of death in people with diabetes, interest in the assessment and treatment of heart disease in these patients has been reawakened. This book examines developing topics from a largely cardiological perspective, covering both pharmacological and non-pharmacological interventions. The DIGAMI study on the use of intravenous insulin infusion at the time of myocardial infarction (MI) has stimulated a large number of discussion papers on the best treatment of MI in the diabetic patient. The UKPDS UKPDS UK Prospective Diabetes Study has shown that treatment of Type 2 diabetes type 2 diabetes n. See diabetes mellitus. does not reduce cardiovascular end-points significantly, but that aggressive treatment of blood pressure can do so. In addition, sub-group analysis from several large cardiovascular trials has shown that treatment with statins, anti-platelet therapy, ACE inhibitors and other drugs will also reduce cardiovascular events in people with diabetes. About the Author Miles Fisher Consultant Physician, Glasgow Royal Infirmary The Glasgow Royal Infirmary (GRI) is a large teaching hospital, operated since 1947 by NHS Scotland, situated on the north-eastern edge of the city centre of Glasgow, Scotland at . John McMurray Professor of Medical Cardiology, British Heart Foundation The British Heart Foundation is a charity organisation in the United Kingdom that funds research, education, care and awareness campaigns aimed to prevent heart diseases in humans. Cardiovascular Research Centre, University of Glasgow The University of Glasgow (Scottish Gaelic: Oilthigh Ghlaschu, Latin: Universitas Glasguensis) was founded in 1451, in Glasgow, Scotland. and Honorary Consultant Cardiologist, Western Infirmary, Glasgow Topics Covered: 1. Epidemiology of vascular disease in diabetes (Susan Laing). 2. Pathogenesis of atherosclerosis and vascular disease in type 2 diabetes (Naveed Sattar and Alistair Cormack). 3. Coronary heart disease coronary heart disease: see coronary artery disease. coronary heart disease or ischemic heart disease Progressive reduction of blood supply to the heart muscle due to narrowing or blocking of a coronary artery (see atherosclerosis). and diabetes (Colin Berry, Miles Fisher and John McMurray). 4. Diabetes and acute coronary syndromes (Colin Berry, Miles Fisher and John McMurray). 5. Diabetes, left ventricular systolic Systolic The phase of blood circulation in which the heart's pumping chambers (ventricles) are actively pumping blood. The ventricles are squeezing (contracting) forcefully, and the pressure against the walls of the arteries is at its highest. dysfunction and chronic heart failure (Michael R MacDonald, Mark C Petrie, Nathaniel M Hawkins and John J V McMurray). 6. Diabetes and hypertension (Gordon T McInnes). 7. Diabetes and strokes/transient ischaemic Adj. 1. ischaemic - relating to or affected by ischemia ischemic attacks (Christopher S Gray and Janice E O'Connell). 8. Diabetes and peripheral arterial disease (Iskandar Idris and Richard Donnelly). 9. Prevention of cardiovascular events in diabetic patients (Markku Laakso). 10. Prevention of diabetes as a means of preventing cardiovascular disease (Stephen J Cleland and Jonathan Shaw). 11. Diabetes for cardiologists (David MacFarlane, Colin Perry and Miles Fisher). For more information, visit http://www.researchandmarkets.com/reports/c74914 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion